Noninvasive Test Detects Heart Rejection

April 17, 1998

Findings of a multi-center study indicate that a noninvasive test is helpful for targeting patients at high risk for rejection following a heart transplant. Clinical results with 30 heart transplant recipients followed for at least three months were reported today at the International Society For Heart and Lung Transplantation Meeting in Chicago, Illinois. Howard J. Eisen, M.D., Medical Director of the Heart Transplantation Unit at Temple University Hospital, reported that "pacemaker guided monitoring has a high predictive value useful in determining heart rejection."

Heart recipients who experience acute cellular rejection within three months of a transplant were identified more often when using this pacemaker technique. In addition, a single diagnosis using an implanted pacemaker would have eliminated the need for more invasive biopsy tests in as much as 71% of the routine follow-up exams. "Based upon our results pacemaker guided monitoring could serve as an early warning for future rejection in heart recipients," says Dr. Eisen. A prospective clinical trial would further define the role of this new technology in detecting rejection and anagement of heart transplant patients.

On average these patients experience approximately two episodes of rejection during the first year with the first three months being the most critical period. Endomyocardial biopsy is the gold standard for diagnosis of transplant rejection. This invasive procedure involves obtaining samples of heart tissue for determining the presence and degree of T lymphocyte infiltration. Patients tolerate the major side effects of endomyocardial biopsy, which can include localized bleeding, infection and arrhythmias. According to Dr. Eisen, "there is clearly a need for a less invasive and therefore more cost effective approach to detecting the early warning signs of heart transplant rejection."

Scientific registry data from the United Network for Organ Sharing (UNOS) indicates that more than 3,900 patients are currently waiting for a heart transplant. Previous reports have indicated that 746 people died in the U.S., in 1996, due to a shortage of organs. The estimated survival rate for that fortunate enough to receive a heart transplant is about 75 to 80 percent.
-end-


Temple University Health System

Related Heart Transplant Articles from Brightsurf:

Does the new heart transplant allocation policy encourage gaming by providers?
A new national policy was created to make determining who receives a heart transplant more fair.

Tiny biological package gets drug right to the 'heart' of transplant rejection
For patients who receive a heart transplant in the near future, the old adage, 'Good things come in small packages,' may become words to live by.

Survival on heart transplant waiting list
Survival of patients on the heart transplant waiting list was examined in this observational study.

Double surgery improves chances for heart transplant in patients with obesity
Pairing bariatric surgery with LVAD heart surgery may be an effective bridge to heart transplant for obese patients.

Changes in US heart transplant waitlist activity, volume during COVID-19 pandemic
National and regional changes in waitlist inactivations and additions, donor recovery and heart transplant volume during the COVID-19 pandemic are described in this observational study.

Racial, gender disparities observed in heart transplant recipients with COVID-19 infection
Researchers suggest focusing on disparities to help identify which patients with a heart transplant may be at higher risk for a worse course of COVID-19 infection.

Characteristics, outcomes of heart transplant recipients with COVID-19
The characteristics, treatment and outcomes of heart transplant recipients who were infected with COVID-19 in New York City are described in this case series.

PET imaging offers new insights into post-transplant care for heart patients
Myocardial blood flow (MBF) and myocardial flow reserve (MFR) have been identified as accurate indicators for graft failure after cardiac transplantation, according to research published in The Journal of Nuclear Medicine.

Massachusetts General Hospital performs first-of-its-kind heart transplant in New England
Mass General Hospital recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death (DCD) donor hearts.

Air pollution may increase mortality risk after heart transplant
Heart transplant recipients who live in areas where particulate matter (PM2.5) air pollution levels reached above national limits for clean air had a 26% higher risk of mortality due to infection, according to a study published today in the Journal of the American College of Cardiology.

Read More: Heart Transplant News and Heart Transplant Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.